Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tae Min Kim

Showing results (261-270 of 588) with videos related to

Pageof 59
Sort By:
Plos One|July 23, 2015
Predictive and Prognostic Value of Ribonucleotide Reductase Regulatory Subunit M1 and Excision Repair Cross-Complementation Group 1 in Advanced Urothelial Carcinoma (UC) Treated with First-Line Gemcitabine Plus Platinum Combination ChemotherapyMiso Kim, Ja Hyeon Ku, Cheol Kwak, et al.
Journal of Behavioral Addictions|November 10, 2016
Targeted exome sequencing for the identification of a protective variant against Internet gaming disorder at rs2229910 of neurotrophic tyrosine kinase receptor, type 3 (NTRK3): A pilot studyJeong-Yu Kim, Jo-Eun Jeong, Je-Keun Rhee, et al.
Iscience|February 3, 2025
Remodeling of tumor microenvironments by EGFR tyrosine kinase inhibitors in <i>EGFR</i>-mutant non-small cell lung cancerSoomin Kim, Jaemoon Koh, Tae Min Kim, et al.
Annals of Nuclear Medicine|July 3, 2013
Prognostic implication of extrarenal metabolic tumor burden in advanced renal cell carcinoma treated with targeted therapy after nephrectomyHai-Jeon Yoon, Jin Chul Paeng, Cheol Kwak, et al.
Cytotherapy|April 24, 2019
NK92-CD16 cells are cytotoxic to non-small cell lung cancer cell lines that have acquired resistance to tyrosine kinase inhibitorsHa-Ram Park, Yong-Oon Ahn, Tae Min Kim, et al.
Molecular Cancer Therapeutics|December 13, 2019
Clinical Application of Next-Generation Sequencing-Based Panel to <i>BRAF</i> Wild-Type Advanced Melanoma Identifies Key Oncogenic Alterations and Therapeutic StrategiesChanghee Park, Miso Kim, Min Jung Kim, et al.
Clinical Lung Cancer|December 21, 2013
Clinical significance of downstaging in patients with limited-disease small-cell lung cancerSe-Il Go, Bhumsuk Keam, Tae Min Kim, et al.
Journal of Neuro-Oncology|May 27, 2017
Impact of interim progression during the surgery-to-radiotherapy interval and its predictors in glioblastoma treated with temozolomide-based radiochemotherapyChan Woo Wee, Eunji Kim, Tae Min Kim, et al.
Human Pathology|December 10, 2022
Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phenotype: a multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expressionJin Ho Paik, Jiwon Koh, Bogyeong Han, et al.
Lung Cancer (Amsterdam, Netherlands)|April 3, 2012
Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patientsHeae Surng Park, June Koo Lee, Dong-Wan Kim, et al.
Pageof 59

Showing results (261-270 of 588) with videos related to

Sort By:
Pageof 59
Plos One|July 23, 2015
Predictive and Prognostic Value of Ribonucleotide Reductase Regulatory Subunit M1 and Excision Repair Cross-Complementation Group 1 in Advanced Urothelial Carcinoma (UC) Treated with First-Line Gemcitabine Plus Platinum Combination ChemotherapyMiso Kim, Ja Hyeon Ku, Cheol Kwak, et al.
Journal of Behavioral Addictions|November 10, 2016
Targeted exome sequencing for the identification of a protective variant against Internet gaming disorder at rs2229910 of neurotrophic tyrosine kinase receptor, type 3 (NTRK3): A pilot studyJeong-Yu Kim, Jo-Eun Jeong, Je-Keun Rhee, et al.
Iscience|February 3, 2025
Remodeling of tumor microenvironments by EGFR tyrosine kinase inhibitors in <i>EGFR</i>-mutant non-small cell lung cancerSoomin Kim, Jaemoon Koh, Tae Min Kim, et al.
Annals of Nuclear Medicine|July 3, 2013
Prognostic implication of extrarenal metabolic tumor burden in advanced renal cell carcinoma treated with targeted therapy after nephrectomyHai-Jeon Yoon, Jin Chul Paeng, Cheol Kwak, et al.
Cytotherapy|April 24, 2019
NK92-CD16 cells are cytotoxic to non-small cell lung cancer cell lines that have acquired resistance to tyrosine kinase inhibitorsHa-Ram Park, Yong-Oon Ahn, Tae Min Kim, et al.
Molecular Cancer Therapeutics|December 13, 2019
Clinical Application of Next-Generation Sequencing-Based Panel to <i>BRAF</i> Wild-Type Advanced Melanoma Identifies Key Oncogenic Alterations and Therapeutic StrategiesChanghee Park, Miso Kim, Min Jung Kim, et al.
Clinical Lung Cancer|December 21, 2013
Clinical significance of downstaging in patients with limited-disease small-cell lung cancerSe-Il Go, Bhumsuk Keam, Tae Min Kim, et al.
Journal of Neuro-Oncology|May 27, 2017
Impact of interim progression during the surgery-to-radiotherapy interval and its predictors in glioblastoma treated with temozolomide-based radiochemotherapyChan Woo Wee, Eunji Kim, Tae Min Kim, et al.
Human Pathology|December 10, 2022
Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phenotype: a multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expressionJin Ho Paik, Jiwon Koh, Bogyeong Han, et al.
Lung Cancer (Amsterdam, Netherlands)|April 3, 2012
Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patientsHeae Surng Park, June Koo Lee, Dong-Wan Kim, et al.
Pageof 59